DSHNHL 2002-1 (MegaCHOEP Phase III)

LHA-ID
7Q0CR2P3X7-9
Study Group
German High Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
Motivation

The goal of the study was to evaluate the therapeutic efficacy of a high-dose therapy with autologous stem cell therapy.

Description
Mega-CHOEP phase III is a randomised study comparing conventional chemoimmunotherapy with R-CHOEP-14 with high-dose chemotherapy plus Rituximab with autologous stem cell transplantation in high-risk patients aged 61 to 80 years with Aggressive Non-Hodgkin’s Lymphoma.
Founding Year
2002
Sponsor
German Cancer Aid
Scientific Speaker
Prof. Dr. Norbert Schmitz
Scientific Speaker eMail
Coordinator
Dr. Maike Nickelsen
Coordinator eMail
Biometry and Data Management
Marita Ziepert
Biometry and Data Management eMail
Registration Number
registered at: ClinicalTrials.gov, number NCT00129090
Human Disease Ontology Concept